Recruiting
Phase 2

Pembrolizumab & Olaparib

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT05366166

Conditions

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Olaparib

Cisplatin

IMRT (intensity modulated radiation therapy)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2025-03-25.